Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder

To see complete record on, please visit this link

Id: NCT04410913

Organisation Name: Saint John's Cancer Institute

Overal Status: Active, not recruiting

Start Date: February 18, 2021

Last Update: January 31, 2022

Lead Sponsor: Keith Heinzerling

Brief Summary: Twenty participants, age 18 or older, who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for moderate to severe Alcohol Use Disorder will be randomized to open-label psilocybin (25 mg) therapy with the Visual Healing Set and Setting platform (N=10) versus psilocybin (25 mg) with a standard Set and Setting platform (N=10). The purpose of this study is to evaluate the feasibility, safety, and tolerability of adding Visual Healing, a nature-themed virtual immersive program, to psilocybin-assisted therapy among participants with alcohol use disorder.

  • Alcohol Use Disorder

Total execution time in seconds: 0.29230189323425